Biogen (NASDAQ: BIIB) reported Q1 EPS of $9.14, $1.40 better than the analyst estimate of $7.74. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.41 billion.

The PDF could not be displayed inside the page, click here to open.

For earnings history and earnings-related data on Biogen (BIIB) click here.